Hormonoprophylaxis and hormonotherapy in the treatment of endometrial adenocarcinoma by means of medroxyprogesterone acetate.
D000230:Adenocarcinoma / Q000188:drug therapy* / Q000532:radiotherapy / Q000601:surgery; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D008525:Medroxyprogesterone / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D009364:Neoplasm Recurrence, Local; D011379:Prognosis; D011883:Radium / Q000627:therapeutic use; D012826:Silicone Elastomers; D014594:Uterine Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy / Q000601:surgery
D012826:Silicone Elastomers; D008525:Medroxyprogesterone; D011883:Radium